Comparison of block among cloned cardiac potassium channels by non-antiarrhythmic drugs

被引:41
|
作者
Lacerda, AE
Kramer, J
Shen, KZ
Thomas, D
Brown, AM
机构
[1] ChanTest Inc, Cleveland, OH 44128 USA
[2] Case Western Reserve Univ, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA
[3] Med Univ Hosp Heidelberg, Dept Cardiol, D-69115 Heidelberg, Germany
关键词
non-antiarrhythmic drugs; acquired long QT syndrome; drug induced QT prolongation; cardiac potassium channels; HERG;
D O I
10.1016/S1520-765X(01)90003-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims A major problem in contemporary therapeutics is to predict those non-antiarrhythmic drugs (nards) which might prolong the QT interval. Block of repolarizing cardiac K+ current is the most likely cause of drug-induced QT prolongation. In this paper we compared six members from four important classes of nards, antihistamines, antipsychotics, antibiotics and prokinetics, for their block of the major repolarizing cardiac potassium currents I-Kr, I-Ks, I-To. and I-Kur. The currents were produced by heterologous expression of HERG (KCNH2), MinK/KvLQT1 (KCNE1/ KCNQ1), Kv4.3 (KCND3) and Kv1.5 (KCNA5) respectively. To evaluate the effects of different cellular backgrounds HERG was expressed stably in HEK 293 and mouse L cells, and transiently in Xenopus laevis oocytes. Methods and Results We measured currents with whole cell patch clamp and calculated IC50 values from dose-response curves at room and body temperatures. In all six cases HERG was the most sensitive target among the cloned K+ channels. HERG channels expressed in different mammalian cell lines had similar IC50 values. IC50 values were five to one hundred times larger when HERG was expressed transiently in Xenopus oocytes. Block was temperature-dependent but the effects were small and variable. For the nards terfenadine, sertindole and cisapride that have been withdrawn from the drug market, the IC50 values for HERG block were nanomolar, within the range for block of the primary target, and therefore within the therapeutic range. Conclusion Cloned ion channel assays are robust preclinical predictors of non-cardiac proarrhythmic drugs. (Eur Heart J Supplements 2001; 3 (Suppl K): K23-K30 (C) 2001 The European Society of Cardiology.
引用
收藏
页码:K23 / K30
页数:8
相关论文
共 50 条
  • [1] Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes
    Sascha Rolf
    Wilhelm Haverkamp
    Martin Borggrefe
    Ulrich Mußhoff
    Lars Eckardt
    Jörg Mergenthaler
    Dirk J. Snyders
    Olaf Pongs
    Erwin-Josef Speckmann
    Günter Breithardt
    Michael Madeja
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2000, 362 : 22 - 31
  • [2] Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes
    Rolf, S
    Haverkamp, W
    Borggrefe, M
    Musshoff, U
    Eckardt, L
    Mergenthaler, J
    Snyders, DJ
    Pongs, O
    Speckmann, EJ
    Breithardt, G
    Madeja, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 362 (01) : 22 - 31
  • [3] Non-antiarrhythmic drugs in atrial fibrillation: A review of non-antiarrhythmic agents in prevention of atrial fibrillation
    Lally, James A.
    Gnall, Eric M.
    Seltzer, Jonathan
    Kowey, Peter R.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (11) : 1222 - 1228
  • [4] BLOCK OF CARDIAC SODIUM-CHANNELS BY ANTIARRHYTHMIC DRUGS
    KODAMA, I
    TOYAMA, J
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1988, 52 (03): : 231 - 237
  • [5] Non-Antiarrhythmic Drugs to Prevent Atrial Fibrillation
    Concepción Moro
    Antonio Hernández-Madrid
    Roberto Matía
    American Journal of Cardiovascular Drugs, 2010, 10 : 165 - 173
  • [6] EFFECTS OF ANTIARRHYTHMIC AND BRADYCARDIAC DRUGS ON CLONED CARDIAC K+ CHANNELS
    YAMAGISHI, T
    ISHII, K
    TAIRA, N
    HEART AND VESSELS, 1995, : 153 - 154
  • [7] Non-Antiarrhythmic Drugs to Prevent Atrial Fibrillation
    Moro, Concepcion
    Hernandez-Madrid, Antonio
    Matia, Roberto
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (03) : 165 - 173
  • [8] Non-antiarrhythmic drugs to prevent atrial fibrillation
    Folkeringa, RJ
    Tieleman, RG
    Crijns, HJGM
    HEART RHYTHM, 2004, 1 (04) : 516 - 518
  • [9] Defining the optimal mix of cardiac ion channels for development of safe non-antiarrhythmic small molecules
    Abernathy, Matthew M.
    Leishman, Derek J.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 139 - 140
  • [10] In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs
    De Bruin, Marie L.
    Langendijk, Pim N. J.
    Koopmans, Richard P.
    Wilde, Arthur A. M.
    Leufkens, Hubert G. M.
    Hoes, Arno W.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (02) : 216 - 223